Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Eunah | - |
dc.contributor.author | Yun, Chae-Ok | - |
dc.date.accessioned | 2021-07-30T07:40:14Z | - |
dc.date.available | 2021-07-30T07:40:14Z | - |
dc.date.issued | 2010-12 | - |
dc.identifier.issn | 1976-6696 | - |
dc.identifier.issn | 1976-670X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/48013 | - |
dc.description.abstract | An often overlooked issue in the field of adenovirus (Ad)mediated cancer gene therapy is its limited capacity for effective systemic delivery. Although primary tumors can be treated effectively with intralesional injection of conventional Ad vectors, systemic metastasis is difficult to cure. Systemic administration of conventional naked Ads leads to acute accumulation of Ad particles in the liver, induction of neutralizing antibody, short blood circulation half-life, non-specific bio-distribution in undesired organs, and low selective accumulation in the target disease site. Versatile strategies involving the modification of viral surfaces with polymers and nanomaterials have been designed for the purpose of maximizing Ad anti-tumor activity and specificity by systemic administration. Integration of viral and non-viral nanomaterials will substantially advance both fields, creating new concepts in gene therapeutics. This review focuses on current advances in the development of smart Ad hybrid nanocomplexes based on various design-based strategies for optimal Ad systemic administration. [BMB reports 2010; 43(12): 781-788] | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY | - |
dc.title | Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity | - |
dc.type | Article | - |
dc.identifier.doi | 10.5483/BMBRep.2010.43.12.781 | - |
dc.identifier.bibliographicCitation | BMB REPORTS, v.43, no.12, pp 781 - 788 | - |
dc.identifier.kciid | ART001503618 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000285816300002 | - |
dc.identifier.scopusid | 2-s2.0-78650691252 | - |
dc.citation.endPage | 788 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 781 | - |
dc.citation.title | BMB REPORTS | - |
dc.citation.volume | 43 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Adenovirus | - |
dc.subject.keywordAuthor | Nanocomplex | - |
dc.subject.keywordAuthor | Nanomaterial | - |
dc.subject.keywordAuthor | Oncolytic adenovirus | - |
dc.subject.keywordAuthor | PEG | - |
dc.subject.keywordAuthor | pHPMA | - |
dc.subject.keywordPlus | POLYMER-COATED ADENOVIRUS | - |
dc.subject.keywordPlus | GROWTH-FACTOR RECEPTOR | - |
dc.subject.keywordPlus | BREAST-CANCER CELLS | - |
dc.subject.keywordPlus | PEGYLATED ADENOVIRUS | - |
dc.subject.keywordPlus | ONCOLYTIC ADENOVIRUS | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | ANTITUMOR-ACTIVITY | - |
dc.subject.keywordPlus | TARGETED DELIVERY | - |
dc.subject.keywordPlus | OVARIAN-CANCER | - |
dc.subject.keywordPlus | NECK-CANCER | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.